Peter Guenter is a member of the Executive Board and CEO of Healthcare at Merck. When he started in January 2021, he set a strategic course towards a clear, focused leadership strategy with the ambition to outperform the pharmaceutical market, serving areas of high unmet medical needs. Under his leadership and guided by our shared purpose, As One for Patients, more than 17,000 employees are dedicated to help create, improve, and prolong lives of patients around the world.
Before joining Merck, Peter served as CEO of the biopharmaceutical company Almirall, based in Barcelona, Spain, from 2017 to 2020. In this time, he led a strategic and cultural transformation to build a global skin-health focused company and brought the business back on track for growth. Prior to this, Peter worked with Sanofi for 22 years where he was driving the Global Diabetes and Cardiovascular business as Executive Vice President and a member of the Executive Committee since 2013. During his tenure there, Peter held a range of global, regional, and local management roles and was among other things responsible for Global Commercial Operations.
Peter Guenter was born in 1962 in Ghent, Belgium. He holds a master’s degree in Physical Education from the Faculty of Medicine and Health Sciences of the University of Ghent.
External positions
• Galapagos N.V., Mechelen, Belgium (publicly listed company), Non-Executive Independent Director
• EFPIA (European Pharmaceutical Trade Association), Brussels, Belgium, Member of the Board of Directors, Incoming Chairman of the Innovation Committee
